| Breakdown |
|---|
Income Statement |
| Total Revenue |
| Gross Profit |
| EBITDA |
| Net Income |
Balance Sheet |
| Total Assets |
| Cash, Cash Equivalents and Short-Term Investments |
| Total Debt |
| Total Liabilities |
| Stockholders Equity |
Cash Flow |
| Free Cash Flow |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £283.57M | 6.41 | 10.69% | ― | 0.50% | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
49 Neutral | £23.63M | -12.98 | -6.15% | ― | 8.14% | 79.37% | |
47 Neutral | £6.13M | ― | -19.96% | ― | 6.48% | 88.46% | |
45 Neutral | £11.25M | ― | ― | ― | -26.54% | -164.52% | |
42 Neutral | £14.11M | ― | -9999.00% | ― | 12.39% | -627.32% |